A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Verónica Rey, Juan Tornín, Juan Jose Alba-Linares, Cristina Robledo, Dzohara Murillo, Aida Rodríguez, Borja Gallego, Carmen Huergo, Alejandro Braña, Aurora Astudillo, Dominique Heymann, Agustín F. Fernández, Mario F. Fraga, Javier Alonso, René Rodríguez
bioRxiv 2023.09.12.557334; doi: https://doi.org/10.1101/2023.09.12.557334